001     282345
005     20240229155039.0
024 7 _ |a 10.1093/jnci/djad178
|2 doi
024 7 _ |a pmid:37632791
|2 pmid
024 7 _ |a 0027-8874
|2 ISSN
024 7 _ |a 0198-0157
|2 ISSN
024 7 _ |a 1460-2105
|2 ISSN
024 7 _ |a altmetric:153349861
|2 altmetric
037 _ _ |a DKFZ-2023-01729
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Chen, Zhishan
|b 0
245 _ _ |a Novel insights into genetic susceptibility for colorectal cancer from transcriptome-wide association and functional investigation.
260 _ _ |a Oxford
|c 2024
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1705587091_16200
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2024 Jan 10;116(1):127-137
520 _ _ |a Transcriptome-wide association studies (TWAS) have been successful in identifying candidate susceptibility genes for colorectal cancer (CRC). To strengthen susceptibility gene discovery, we conducted a large TWAS and an alternative splicing-TWAS (sp-TWAS) in CRC using improved genetic prediction models and performed in-depth functional investigations.We analyzed RNA-sequencing (RNA-seq) data from normal colon tissues and genotype data from 423 European descendants to build genetic prediction models of gene expression and alternative splicing, and evaluated model performance using independent RNA-seq data from normal colon tissues of the Genotype-Tissue Expression Project. We applied the verified models to genome-wide association studies (GWAS) summary statistics among 58,131 CRC cases and 67,347 controls of European ancestry to evaluate associations of genetically predicted gene expression and alternative splicing with CRC risk. We performed in vitro functional assays for three selected genes in multiple CRC cell lines.We identified a total of 57 putative CRC susceptibility genes, which included the 48 genes from TWAS and 15 genes from sp-TWAS, at Bonferroni-corrected P < 0.05. Of these, 16 genes were not previously implicated in CRC susceptibility, including a gene PDE7B (6q23.3) at locus previously not reported by CRC GWAS. Gene knockdown experiments confirmed the oncogenic roles for two unreported genes, TRPS1 and METRNL, and a recently reported gene, C14orf166.This study discovered new putative susceptibility genes of CRC and provided novel insights into the biological mechanisms underlying CRC development.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Alternative splicing
|2 Other
650 _ 7 |a Colorectal cancer
|2 Other
650 _ 7 |a TWAS
|2 Other
650 _ 7 |a susceptibility genes
|2 Other
700 1 _ |a Song, Wenqiang
|b 1
700 1 _ |a Shu, Xiao-Ou
|b 2
700 1 _ |a Wen, Wanqing
|b 3
700 1 _ |a Devall, Matthew
|b 4
700 1 _ |a Dampier, Christopher
|b 5
700 1 _ |a Moratalla-Navarro, Ferran
|b 6
700 1 _ |a Cai, Qiuyin
|b 7
700 1 _ |a Long, Jirong
|b 8
700 1 _ |a Van Kaer, Luc
|b 9
700 1 _ |a Wu, Lan
|b 10
700 1 _ |a Huyghe, Jeroen R
|b 11
700 1 _ |a Thomas, Minta
|b 12
700 1 _ |a Hsu, Li
|b 13
700 1 _ |a Woods, Michael O
|b 14
700 1 _ |a Albanes, Demetrius
|b 15
700 1 _ |a Buchanan, Daniel D
|b 16
700 1 _ |a Gsur, Andrea
|b 17
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 18
|u dkfz
700 1 _ |a Vodicka, Pavel
|b 19
700 1 _ |a Wolk, Alicja
|b 20
700 1 _ |a Marchand, Loic Le
|b 21
700 1 _ |a Wu, Anna H
|b 22
700 1 _ |a Phipps, Amanda I
|b 23
700 1 _ |a Moreno, Victor
|b 24
700 1 _ |a Ulrike, Peters
|b 25
700 1 _ |a Zheng, Wei
|b 26
700 1 _ |a Casey, Graham
|b 27
700 1 _ |a Guo, Xingyi
|b 28
773 _ _ |a 10.1093/jnci/djad178
|g p. djad178
|0 PERI:(DE-600)1465951-7
|n 1
|p 127-137
|t Journal of the National Cancer Institute
|v 116
|y 2024
|x 0027-8874
909 C O |p VDB
|o oai:inrepo02.dkfz.de:282345
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2022-11-18
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-18
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JNCI-J NATL CANCER I : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b JNCI-J NATL CANCER I : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21